AltRx Pricing: Limited-Time Rates and Unknown Refill Costs Explained

Last reviewed: September 8, 2026 Last updated: September 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

The short answer

AltRx advertises compounded semaglutide injection at $89/month and compounded tirzepatide injection at $149/month on month-to-month billing, with lower per-month equivalents available through prepaid multi-month plans, through September 5, 2026. The promotional pricing includes medical oversight, medication, consultation, support, and shipping—no separate membership fee—and remains the same at all doses. The standard ongoing rate after the promotion ends is not disclosed on the pricing pages captured September 4, 2026, making total cost over time uncertain. One Trustpilot review and a Reddit thread allege a full annual prebill despite selecting month-to-month, though AltRx's advertised terms state "cancel anytime" with monthly billing available. All AltRx figures below are promotional rates ending September 5, 2026; confirm current standard pricing at checkout.

AltRx pricing at a glance (promotional, ends September 5, 2026)

Inclusions: Medical oversight, medication, consultation, support, and shipping are included in the promotional rates. No separate membership fee. Pricing is the same at all doses. (AltRx promotional pricing page, captured September 4, 2026)

Promotional deadline: The pricing grid above is labeled as valid through September 5, 2026. Standard ongoing rates after that date are not disclosed on the pricing pages reviewed.

What's included in AltRx pricing

AltRx's promotional rate is an all-inclusive figure covering:

• Medication: Compounded semaglutide or tirzepatide injection shipped monthly
• Medical oversight: Consultation with a licensed provider to determine appropriateness
• Support: Ongoing access to the care team
• Shipping: Delivery at no additional charge

There is no separate membership fee, lab fee, or visit fee during the promotional period. The advertised price is the total monthly cost, and the same rate applies at all doses—patients escalating from a starter dose to a maintenance dose pay the same monthly amount. (AltRx promotional pricing page, captured September 4, 2026)

Month-to-month vs. prepaid plans: promotional first-year cost

AltRx offers four plan durations during the promotion, each with a different per-month equivalent and upfront commitment. The table below shows the total first-year cost under each structure, assuming the promotional rate continues for the full 12 months. Because the promotion ends September 5, 2026, and no standard refill pricing is disclosed, actual 12-month cost may differ if the promotion does not renew or if standard rates apply to later refills.

Calculations assume promotional rates continue for renewals; promotion ends September 5, 2026, and renewal pricing is not disclosed. All figures are our calculation based on advertised promotional per-month equivalents.

The 12-month prepaid plan delivers the lowest per-month equivalent ($75 semaglutide, $125 tirzepatide) and the lowest total first-year cost, but requires the largest upfront payment and the longest commitment. The month-to-month plan carries the highest per-month rate and the highest total first-year cost under promotional pricing, but offers the most flexibility and the smallest initial financial commitment.

AltRx promotional pricing vs. PlexusDx standard pricing

PlexusDx publishes flat, ongoing rates for compounded semaglutide and tirzepatide injection with no promotional deadlines or rate changes. The table below compares AltRx's promotional month-to-month rate (ending September 5, 2026) to PlexusDx's standard month-to-month rate, which does not expire and includes the same scope of service: medication, provider visit, ongoing support, and shipping.

AltRx's promotional month-to-month rate is substantially lower than PlexusDx's standard month-to-month rate for both medications. However, AltRx's promotional pricing ends September 5, 2026, and the standard refill rate after that date is not disclosed on the pricing pages captured September 4, 2026. PlexusDx's rates are ongoing and do not change based on a promotional calendar. Total cost over time depends on whether AltRx's promotional rate renews, what the standard rate is if the promotion does not renew, and whether the patient remains eligible for either program's medication.

PlexusDx also offers longer-term prepaid options that reduce the per-month equivalent: $169/month for a 3-month prepaid plan ($507 upfront) and $149/month for a 6-month prepaid plan ($894 upfront) for semaglutide injection; $269/month for a 3-month prepaid plan ($807 upfront) and $249/month for a 6-month prepaid plan ($1,494 upfront) for tirzepatide injection. These prepaid per-month rates are our calculation and remain above AltRx's promotional prepaid equivalents, but they reflect a published, non-promotional standard rate structure.

The unknown: what happens after September 5, 2026?

AltRx's pricing pages, captured September 4, 2026, label the entire rate grid as promotional through September 5, 2026. The pages do not disclose the standard ongoing rate that will apply after the promotion ends. This creates cost uncertainty for patients who begin treatment during the promotional window and continue beyond the deadline.

Possible scenarios include:

• The promotion renews or extends at the same or similar rates for existing patients.
• Pricing reverts to a higher standard rate for refills placed after September 5, 2026.
• Pricing varies by patient based on enrollment date, plan duration, or other factors not disclosed in the promotional material.

Because no standard pricing is published, patients comparing AltRx to other providers cannot calculate a reliable 12-month cost beyond the promotional period. The advertised terms state "cancel anytime," suggesting patients can discontinue without penalty if the post-promotion rate is unacceptable, but the economic decision depends on information not available at the time of this analysis.

Billing practice allegation

One 1-star review on Trustpilot and a Reddit thread allege that AltRx charged the full annual amount upfront despite the reviewer selecting month-to-month billing. (Trustpilot, captured September 4, 2026) The advertised promotional terms state "cancel anytime" with a monthly billing option available at $89/month for semaglutide and $149/month for tirzepatide. The allegation is a single consumer report and does not establish a systemic billing practice, but it introduces a specific operational concern: confirm the billing structure and refund terms at intake and review the charge authorization before approving payment.

Decision factors: promotional pricing vs. rate certainty

AltRx's promotional pricing offers a low entry cost and a range of prepaid options that reduce the per-month equivalent further. The promotion is time-limited, and the standard refill rate is not disclosed. PlexusDx's pricing is higher on a month-to-month basis but is published as a flat, ongoing rate with no promotional expiration. The choice depends on three factors:

• Time horizon: Patients starting treatment before September 5, 2026, and planning short-term use (one to three months) benefit from the promotional rate with limited exposure to post-promotion pricing. Patients planning long-term treatment face cost uncertainty after the promotion ends.
• Upfront budget: AltRx's lowest per-month equivalent requires $900 (semaglutide) or $1,500 (tirzepatide) upfront. PlexusDx's 6-month prepaid plan requires $894 (semaglutide) or $1,494 (tirzepatide) upfront at a higher per-month equivalent but with no promotional deadline.
• Risk tolerance: AltRx's promotional pricing trades a lower initial rate for unknown future pricing. PlexusDx's published rates are higher initially but stable and predictable.

Choose AltRx if…

AltRx's promotional pricing may fit patients who:

• Start treatment before September 5, 2026, and plan short-term use (one to three months) where the promotional rate applies to the entire treatment window.
• Are comfortable with cost uncertainty after the promotion ends and can discontinue or switch providers if the standard rate is unacceptable.
• Have upfront budget for a prepaid multi-month plan and want the lowest possible per-month equivalent during the promotional period ($75/month semaglutide on the 12-month plan, $125/month tirzepatide on the 12-month plan).
• Prioritize immediate cost savings over long-term rate predictability.

Confirm the post-promotion refill rate before committing to a plan longer than the promotional window, and verify the billing structure and refund terms at intake in light of the billing allegation documented above.

Choose PlexusDx if…

PlexusDx may fit patients who:

• Plan long-term treatment (six months or longer) and want a published, stable rate with no promotional deadlines or post-promotion rate changes.
• Prefer transparency about total cost over time, with refill pricing disclosed upfront rather than revealed after a promotional period ends.
• Value operational simplicity: one rate structure, no promotional calendar, no need to confirm whether the promotional rate renews or what the standard rate will be.
• Are considering semaglutide injection at $189/month month-to-month, $169/month on a 3-month prepaid plan, or $149/month on a 6-month prepaid plan, or tirzepatide injection at $289/month month-to-month, $269/month on a 3-month prepaid plan, or $249/month on a 6-month prepaid plan, all with standard ongoing rates that do not expire.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026). PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician reviews your intake and determines whether a prescription is appropriate for your individual situation.

Methodology and freshness

This analysis is based on AltRx's promotional pricing pages captured September 4, 2026, including the offer grid at altrx.com/glp1/offer-v9-fl and the homepage at altrx.com. The promotional deadline of September 5, 2026, is stated on the pricing page. No standard (non-promotional) ongoing rate was disclosed on the pages reviewed. The billing practice allegation is drawn from a Trustpilot review captured September 4, 2026. PlexusDx pricing is current as of September 8, 2026. All 12-month cost calculations and prepaid per-month equivalents are our calculation based on the advertised rates. Readers should confirm current pricing, post-promotion rates, billing structure, and refund terms directly with AltRx at checkout, and confirm PlexusDx pricing on the product pages before making a decision.

Frequently Asked Questions

Does AltRx charge a separate membership fee?

No. AltRx's promotional pricing includes medical oversight, medication, consultation, support, and shipping in one figure. No separate membership fee is charged during the promotional period ending September 5, 2026. Whether a membership fee applies after the promotion ends is not disclosed in the materials captured.

What is AltRx's refill price after the promotion ends?

AltRx's promotional pricing pages, captured September 4, 2026, do not disclose the standard refill rate that will apply after September 5, 2026. Confirm the ongoing rate directly with AltRx before committing to a plan that extends beyond the promotional deadline.

Is the same AltRx price charged at all doses?

Yes. AltRx states that the promotional rate is the same at all doses. A patient escalating from a starter dose to a higher maintenance dose pays the same monthly amount during the promotional period. Whether this policy continues after the promotion ends is not disclosed.

What is the upfront cost for AltRx's lowest per-month rate?

AltRx's lowest promotional per-month equivalent is $75 for semaglutide and $125 for tirzepatide on the 12-month prepaid plan. The upfront cost is $900 for semaglutide and $1,500 for tirzepatide, paid in full at enrollment. This is a promotional rate ending September 5, 2026.

Can I cancel AltRx anytime, or am I locked into a prepaid plan?

AltRx advertises "cancel anytime" terms on its promotional pages. One Trustpilot review alleges a full annual prebill despite selecting month-to-month. Confirm the cancellation policy, refund terms, and whether prepaid amounts are refundable if you cancel early, directly with AltRx at intake before authorizing payment.

Sources

• AltRx promotional pricing page (altrx.com/glp1/offer-v9-fl), accessed September 4, 2026
• AltRx homepage (altrx.com), accessed September 4, 2026
• AltRx compounded tirzepatide product page (altrx.com/products/compounded-tirzepatide), accessed September 4, 2026
• Trustpilot review of AltRx, accessed September 4, 2026
• PlexusDx product pages (plexusdx.com), accessed September 8, 2026
• PlexusDx Trustpilot profile, accessed September 4, 2026

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.